Furthermore, a comparative scRNA-seq study across colorectal, lung, ovarian, and breast cancers, including tumor and matched normal tissues, revealed higher expression of fascin in intratumoral DCs compared to other tumor-infiltrating immune cells, endothelial cells, and fibroblasts [48]. This evidence concerns the gene FSCN1 and neoplasm.